Your User Name is:
Workshop Timeline:06/01/2024: Participants will have access to contours (1st Contouring exercise)08/01/2024: End of the window for 1st Contouring exercise03/01/2025: Participants will have access to contours (2nd Contouring exercise)05/01/2025: End of the window for 2nd Contouring exerciseFaculty:Lucas Castro Mendez, MDGlenn Bauman, MD, FRCPCAsk (Contouring):In use of this information, please contour intraprostatic dominant lesion(s) as you see fit in images uploaded at EduCase platform (EduCase patient #03). Utilize the nomeclature available in the “structure list” to contour dominant lesion(s). If multiple lesions are contoured in either the mpMR or PSMA-PET scans combine them together (Union) into GTV_Boost_MR and/or GTV_Boost_PSMA, respectively. Finally, combine these volumes to create GTV_Boost_Final.Disabled Contours: All contours disabledEnabled Contours: NoneResource Files: - DIL Case Vignettes- EduCase Training Video: How to contour, complete the homework, and save/submit - EduCase User Guide
Workshop Timeline:Singapore On-Target [SPOT] Contouring Course August 6-7, 2022Faculty:Dr. Bala Vellayappan: Senior Consultant Radiation Oncologist & Research DirectorDr. David Tan: Consultant Radiation Oncologist Asian Alliance Radiation & Oncology Contour Homework:TBDDisabled Contours: All contours disabledEnabled Contours: None Resource Files: - SPOT Contouring Vignette - EduCase Training Video: How to contour, complete the homework, and save/submit- EduCase User Guide
Trial title:Prostate oncologic therapy while ensuring neurovascular conservation (POTEN-C): a Phase II randomized controlled trial of stereotactic ablative body radiotherapy (SAbR) with or without neurovascular sparing for erectile function preservation in localized prostate cancerDescription:This randomized multi-center phase II trial will investigate whether neurovascular element sparing using a dose-painting technique during rectal spacer facilitated stereotactic ablative body radiotherapy (SAbR) will improve sexual function outcomes during treatment of localized prostate cancer. Key to its implementation will be quality controlled MR/CT fusion based delineation of neurovascular bundles and internal pudendal arteries and careful dose-painting de-escalation of dose in prostate gland adjacent to at least one neurovascular bundle where there is no MRI evidence of clinical significant prostate cancer. The EduCase modules for this trial will help credential and prepare investigators during trial launch.Principle Investigator:Neil Desai, MDHomework:pendingDisabled Contours: All contours disabledEnabled Contours: NoneResource Files:Vignette pending...- EduCase Training Video: How to contour, complete the homework, and save/submit- EduCase User Guide- EduCase Metrics Guide (basic)
Prostate Contouring Session (US): Talar Derashodian, MDFri, May 19, 2017, 7:00 AM – Sat, May 20, 2017, 5:00 AM SST - Saint James Club, 1145 Avenue Union, Montréal, QC H3B 3C2, CanadaContour Homework: Please contour the following:1. Prostate 2. Urethra 3. Rectum Disabled Contours: All "Author's Structures" are disabledEnabled Contours: NoneResource Documents: Ultrasound Vignette EduCase Features and Guidelines